Zydus announces Phase IV EVIDENCES-XI trial to generate RWE of Saroglitazar Mg in NAFLD patients… EP News Bureau Jun 9, 2023 Phase IV EVIDENCES- XI trial will enroll approximately 1500 NAFLD patients with comorbidities
